|
Hematúria
Microscópica (Tabelas)
|
TABLE 1
Risk Factors for Significant Disease
in Patients with Microscopic Hematuria
Smoking history
Occupational exposure to chemicals or dyes
(benzenes or aromatic amines)
History of gross hematuria
Age >40 years
History of urologic disorder or disease
History of irritative voiding symptoms
History of urinary tract infection
Analgesic abuse
History of pelvic irradiation
TABLE 3
Imaging Modalities
for Evaluation of the Urinary Tract
Modality
Advantages and disadvantages
Intravenous
urography
Considered by many to be best initial study for evaluation of
urinary tract
Widely available and most cost-efficient in most centers
Limited sensitivity in detecting small renal masses
Cannot distinguish solid from cystic masses;therefore,
further lesion characterization by ultrasonography,computed
tomography or magnetic resonance imaging is necessary
Better than ultrasonography for detection of transitional cell
carcinoma in kidney or ureter
Ultrasonography
Excellent
for detection and characterization of renal cysts
Limitations in detection of small solid lesions (<3 cm)
Computed
tomography
Preferred
modality for detection and characterization of solid
tomography renal masses
Detection rate for renal masses comparable to that of
magnetic resonance imaging,but more widely available
and less expensive
Best modality for evaluation of urinary stones,renal and
perirenal infections,and associated complications
Sensitivity of 94%to 98%for detection of renal stones,
compared with 52%to 59%for intravenous urography
and 19%for ultrasonography
TABLE
1
Substances and Medications Affecting Urine Color |
Artificial
food coloring
Beets
Berries
Chloroquine (Aralen)
Furazolidone (Furoxone)
Hydroxychloroquine (Plaquenil)
Nitrofurantoin (Furadantin)
Phenazopyridine (Pyridium)
Phenolphthalein
Rifampin (Rifadin)
|
TABLE
2
Mechanisms by Which Selected Drugs May Cause Hematuria |
| Mechanism
|
Drugs
|
| Interstitial
nephritis |
Captopril
(Capoten)
Cephalosporins
Chlorothiazide (Diuril)
Ciprofloxacin (Cipro)
Furosemide (Lasix)
NSAIDs
Olsalazine (Dipentum)
Omeprazole (Prilosec)
Penicillins
Rifampin (Rifadin)
Silver sulfadiazine (Silvadene)
Trimethoprim-sulfamethoxazole (Bactrim, Septra)
|
| Papillary
necrosis |
Acetylsalicylic
acid (aspirin)
NSAIDs
|
| Hemorrhagic
cystitis |
Cyclophosphamide
(Cytoxan)
Ifosfamide (Ifex)
Mitotane (Lysodren)
|
| Urolithiasis |
Carbonic
anhydrase inhibitors
Dichlorphenamide (Daranide)
Indinavir (Crixivan)
Mirtazapine (Remeron)
Ritonavir (Norvir)
Triamterene (Dyrenium)
|
TABLE
3
Glomerular and Nonglomerular Causes of Hematuria |
| Glomerular
causes |
Nonglomerular
causes |
|
Primary
glomerulonephritis
IgA
nephropathy (Berger's disease) Postinfectious glomerulonephritis
Membranoproliferative glomerulonephritis
Focal glomerular sclerosis
Rapidly progressing glomerulonephritis
Secondary
glomerulonephritis
Lupus
nephritis
Henoch-Schönlein syndrome
Vasculitis (polyarteritis nodosa, Wegener's
granulomatosis)
Essential mixed cryoglobulinemia
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Medications (i.e., interstitial nephritis,
analgesic nephropathy)
Familial
conditions
Thin
glomerular basement membrane nephropathy
Hereditary nephritis (Alport's syndrome)
Fabry's disease
Exercise12-14
|
Conditions
affecting renal parenchyma
Renal
tumors (renal cell carcinoma, angiomyolipoma, oncocytoma)
Vascular disorders (nutcracker syndrome,15
malignant hypertension, sickle cell trait or disease,
arteriovenous malformation, renal vein thrombosis or infarct,
transplant rejection)
Metabolic disorder (hypercalciuria, hyperuricuria)
Familial condition (polycystic kidney disease, medullary sponge
kidney)
Infection (acute or chronic pyelonephritis,
tuberculosis, cytomegalovirus infection, infectious mononucleosis)
Papillary necrosis
Extrarenal
conditions
Tumors
(renal pelvis, ureter, bladder, prostate)
Benign prostatic hyperplasia
Stone or foreign body
Infections (cystitis, prostatitis, urinary schistosomiasis,
tuberculosis, condyloma acuminatum)
Systemic bleeding disorder or coagulopathy
Trauma
Radiation therapy
Indwelling catheters
Drugs (heparin, warfarin [Coumadin], cyclophosphamide [Cytoxan])
|
TABLE
4
Physical Examination Findings and Associated Causes of Hematuria
|
| Physical
examination finding |
Cause
of hematuria |
| General
(systemic) examination |
|
| Severe
dehydration |
Renal
vein thrombosis |
| Peripheral
edema |
Nephrotic
syndrome, vasculitis |
| Cardiovascular
system |
|
| Myocardial
infarction |
Renal
artery embolus or thrombus |
| Atrial
fibrillation |
Renal
artery embolus or thrombus |
| Hypertension
|
Glomerulosclerosis
with or without proteinuria |
| Abdomen
|
|
| Bruit
|
Arteriovenous
fistula |
| Genitourinary
system |
|
| Enlarged
prostate |
Urinary
tract infection |
| Phimosis
|
Urinary
tract infection |
| Meatal
stenosis |
Urinary
tract infection |
TABLE
5
Risk Factors for Urothelial Carcinoma |
|
Cigarette
smoking
Occupational exposures
Aniline
dyes
Aromatic amines
Benzidine
Dietary
nitrites and nitrates
Analgesic abuse (e.g., phenacetin)
Chronic cystitis and bacterial infection associated with urinary
calculi and obstruction of the upper urinary tract
Urinary schistosomiasis
Cyclophosphamide (Cytoxan)
Pelvic irradiation
|
TABLE
6
Risk Factors for Contrast Uropathy |
Dehydration
Diabetes with azotemia
Cardiac decompensation
History of allergy
Asthma
Hay fever
Seafood allergy
Others, including allergic reactions to antibiotics
Previous reaction to contrast media
Renal insufficiency |
|